Aldeyra Therapeutics Inc (NASDAQ:ALDX)

12.35
Delayed Data
As of Jun 11
 -0.07 / -0.56%
Today’s Change
3.95
Today|||52-Week Range
15.95
+80.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization18.9K22.8K24.2K24.0K
 
 
 
 
 
 
Operating ExpensesGross Income-18.9K-22.8K-24.2K-24.0K
 
 
 
 
 
General Expenses10.9M11.1M10.8M13.8M
 
 
 
 
 
Research And Development7.9M8.5M7.8M10.7M
 
 
 
 
 
Total Operating Expenses10.9M11.1M10.8M13.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.9M-11.1M-10.8M-13.8M
 
 
 
 
 
Extraordinary Credit0.000.000.0049.8K
 
 
Extraordinary Charge0.000.00-6.6M0.00
 
 
Interest Expense On Debt28.8K63.5K2.0K28.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.8M-10.6M-16.9M-13.3M
 
 
 
 
 
Income Taxes0.000.00-1.3M0.00
 
 
Net Income-10.8M-10.6M-15.6M-13.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.0M26.2M27.1M27.0M
 
 
 
 
 
Shares To Calculate EPS Diluted21.0M26.2M27.1M27.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.52-$0.39-$0.58-$0.49
 
 
 
 
 
EPS Diluted-$0.52-$0.41-$0.58-$0.49